Carcinoma, Renal Cell — Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034
Citation(s)
An Open-Label, Two-Part Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Pazopanib (GW786034) and the Absorption, Distribution, Metabolism and Elimination of a Single Oral [14C] Labeled Dose of Pazopanib in Subjects With Solid Tumor Malignancies